Capstone Project

Each M-TRAM student pursues a capstone project (TRIP: Translational Research Individual Project) requiring  a minimum of 10 hours per week from the second through the fourth quarters. It is an enriching opportunity for each student to pursue a deeper analysis and understanding of a topic of personal interest. TRIP gives students the opportunity to test a hypothesis, develop an experimental plan, interpret results, and understand the future research plan. The completion of the M-TRAM degree includes a final capstone presentation that demonstrates a full and complete understanding of the student's work in the program. 

CAPSTONE PROJECTS 2023/24

ETHAN TAI

  • AI/machine learning enabled structure-based drug discovery.
  • Capstone advisor: Russ Altman, MD, Ph.D., Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science), past chairman of the Bioengineering Department

CARA LOW

  • “Pharmacological validation of clinically relevant cancer targets “
  • Capstone advisor: Nathanael Gray, MD, Ph.D., Krishnan Shah Family Professor of Chemical and Systems Biology, Co-Lead of Medicinal Chemistry (IMA: Innovative Medicines Accelerator)

ANANYA JAIN

  • “Developing therapeutics for pulmonary arterial hypertension (PAH).”
  • Capstone advisor: Vinicio de Jesus Perez, MD, Associate Professor of Pulmonary and Critical Care Medicine

MAXIMILIAN NISSLEIN

  • “Tumor infiltrating lymphocyte (TIL) therapy for solid tumors (melanoma)”
  • Capstone advisor: Allison Betof Warner, MD, PhD, Assistant Professor of Medicine (Oncology), Director of the Melanoma Program and Faculty Leader of the Melanoma|Cutaneous Oncology Clinical Research Group in the SCI-Cancer Clinical Trials Office

ADRIANA CHU

  • “Glycoproteomics based early cancer detection.”
  • Capstone advisor: Carolyn Bertozzi, PhD, Baker Family Director of Stanford Sarafan ChEM-H, Anne T. and Robert K. Bass Professor, School of Humanities and Sciences
  • Industry collaboration with InterVenn Biosciences (company)

JESSICA LAYNE

  • "Anti-Myc cancer therapeutics"
  • Capstone advisor: Dean Felsher, MD, PhD, Professor of Medicine (Oncology) and of Pathology, TRAM Director, M-TRAM Faculty Director, Co-Director Cancer Nanotechnology Program, Department of Radiology, Stanford School of Medicine, Director of Admissions/Associate Director, Medical Scientist Training Program, Director of Advanced Residency Training Program, Stanford University School of Medicine, Co-Director of Spectrum KL2 Mentored Development Program, Stanford University, School of Medicine

YANAN DING

  • "AI enabled drug discovery for breast cancer"
  • Capstone advisor: Christina Curtis, MD, PhD, Professor of Medicine, Genetics and Biomedical Data Science, Director of Artificial Intelligence and Cancer Genomics, Director - Breast Cancer Translational Research (Stanford Cancer Institute), Co-Director - Molecular Tumor Board, Stanford Cancer Institut

ZAIN DIBIAN

  • "T-reg cell immunotherapy for graft vs. host disease"
  • Capstone advisor: Everett Meyer, MD, Associate Professor of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy

SHONA ALLEN

  • "Developing a therapeutic for SMA (spital muscular atrophy) neurological disorder: computational analysis of clinical trial data"
  • Capstone advisor: Jacinda Sampson, MD, PhD, Clinical Professor of Neurology and Neurological Sciencies

PETER CAROLINE

  • "Immunotherapy for IBD (inflammatory bowel disease)"
  • Capstone advisor: Sidhartha Sinha, MD, Assistant Professor of Medicine (Gastroenterology and Hepatology), Director of Digital Health and Innovation, Division of Gastroenterology & Hepatology   

CHLOE GERUNGAN

  • "Developing a therapeutic for infectious disease (malaria)"
  • Capstone advisor: Prasanna Jagannathan, MD, Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

JOEY OLSHAUSEN

  • "Drug repurposing for treatment of cardio valve disease"
  • Capstone advisor: Ian Chen, MD, Assistant Professor of Medicine (Cardiovascular Disease) and of Radiology (Veterans Affairs), Director, Translational Cardiovascular Research Laboratory, Veterans Affairs Palo Alto Health Care System, Director, VA/PAVIR Summer Research Program

Capstone Projects 2022-23

CHRIS ABOUJUDOM

  • Development of Novel MYC-directed Anti-cancer Therapeutics
  • Capstone advisor: Dean Felsher, MD Ph.D., Professor of Medicine (Oncology) and of Pathology, M-TRAM Program Director,

McKAY GOHAZRUA BUTLER

  • “Developing protocols for isolation and purification of MYC-derived cancer extracellular vesicles (EVs) for improved diagnosis and monitoring of cancer.“
  • Capstone advisor: Dean Felsher, MD Ph.D., Professor of Medicine (Oncology) and of Pathology, M-TRAM Program Director

NIRK E. QUISPE CALLA, MD

  • “Development of a combined cancer vaccine and immunotherapy (anti-PD-L1) delivery using dendritic cell-based microbubbles against triple-negative breast cancer”
  • Capstone advisor: Ramasamy Paulmurugan, PhD, Professor of Radiology, Molecular Imaging Program at Stanford

FRANK LIN

  • “Investigate the roles and therapeutic value of human anti-phagocytotic genes in augmenting CAR-T cell therapy”
  • Capstone advisor: Crystal Mackall, MD (Capstone Primary Advisor Faculty Mentor), Founding Director of the Stanford Center for Cancer Cell Therapy, Professor of Pediatrics and Medicine

JULIAN WOLF, MD

  • "High-resolution proteomic profiling of aqueous humor liquid biopsies as a diagnostic and prognostic tool for choroidal melanoma"
  • Capstone advisor: Vinit Mahajan, MD, PhD, Professor of Ophthalmology, Vice Chair for Research (Ophthalmology)
  • Capstone advisor: Nima Aghaeepour, PhD, Associate Professor of Anesthesiology, Pediatrics and Biomedical Science

·  

Applications portal is now closed  

for the 2024/2025 academic year

We will be accepting applications for 2025/26

in the Fall of 2024.

APPLY HERE


Questions? Contact us!
mtramstudies@stanford.edu

Important Dates

September 2023 to January 2024:

  • Applications accepted for 2024/25

 

December 8, 2023:

  • M-TRAM info session webinar for prospective students (register here)

 

January 31, 2024:

  • Applications are due for 2024/25

 

April, 2024:

  • Admission Decisions

 

Sept. 9, 2024:

  • M-TRAM research symposium and New Students Orientation (in person) - stay tuned for registration info

 

Sept. 23, 2024:

  • First day of classes at Stanford (M-TRAM program starts)

 

Interested in Becoming an M-TRAM Industry Partner?

We welcome inquiries from biotechnology, pharmaceutical and other health care organizations interested in learning about opportunities to partner with M-TRAM: 

mtramstudies@stanford.edu